Dennis Falzon

6 ta ish

World Health Organization, Global TB Programme, Geneva, Switzerland

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   MaqolaTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Multidrug-resistant Tuberculosis in Central Asia

   Helen Cox, Juan Daniel Orozco, Roy Male +6

   MaqolaTuberculosis Research and EpidemiologyEmerging infectious diseases20046 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.020023

3. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/openalex/2017.review-article.000004

4. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.195695

5. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

   ABIABI:AkademIndex/openalex/2019.article.000020

6. Dust exposure and respiratory health amongst children in the environmental disaster zone of Karakalpakstan, Central Asia: preliminary findings of the ASARD project.

   S. O’Hara, Giles Wiggs, Johannah Wegerdt +4

   MaqolaTherapeutic Uses of Natural ElementsWIT transactions on biomedicine and health20011 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.104762